Publication | Closed Access
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2.2K
Citations
32
References
2007
Year
UrologySurgical OncologyOncologyGenitourinary CancerInterferon Alfa-2aCancer TreatmentMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1